Eli Lilly

David Eisenberg got a call this month from a finance official at a U.S.-based multinational company. The executive wanted to know whether the company had derivatives in its retirement portfolio.“We explained that they don’t,” said Mr. Eisenberg, an investment adviser with Buck, a New York-based pension-actuary and human-resources consulting firm. “They were worried that if they were using derivatives they were exposed to risk.”  The U.K. pension blowup has left many U.S. companies pushing…

The Biden administration is planning for an end to its practice of paying for Covid-19 shots and treatments, shifting more control of pricing and coverage to the healthcare industry in ways that could generate sales for companies—and costs for consumers—for years to come.The Department of Health and Human Services intends to hold a planning session on Aug. 30 that would bring together representatives from drugmakers, pharmacies and state health departments with a stake in a Covid-19 treatment industry. Both the Trump and…

Eli Lilly LLY -1.46% & Co. spoke out against Indiana’s new abortion law, saying the restrictions could hurt the pharmaceutical company’s ability to keep and attract employees and will lead it to plan more hiring outside the state.The Saturday statement came after Indiana’s governor on Friday signed a near-total ban on abortions shortly after lawmakers approved it. The ban takes effect Sept. 15 and includes exceptions. Lilly, based in Indianapolis, said the company…

Obesity kills millions every year, yet drug companies and doctors have mainly focused on treating diseases caused by excess pounds, such as diabetes, rather than waistlines themselves. One reason for that is the stigma that comes with the condition: Many in the medical field still see excess weight as a lifestyle condition that should be addressed solely through healthier eating and exercise. A much bigger problem, though, has been the dearth of safe and effective drugs. That has left the gigantic business of weight loss…

Eli Lilly & Co. posted a 4% decline in second-quarter revenue, driven by a drop in sales of the company’s Covid-19 antibody treatment. The pharmaceutical company on Thursday cut its profit outlook for the year as the stronger U.S. dollar impacts results. Lilly said lower prices and currency translation also contributed to the declining sales, which came in below Wall Street expectations. For the three months ended June 30, Lilly…

Eli Lilly & Co. said it plans to begin commercial sales of its Covid-19 monoclonal antibody treatment to states, hospitals and other healthcare providers this month, as the federal government’s supply of the drug is nearly depleted.The move marks a shift away from the way Lilly’s drug and most other Covid-19 treatments and vaccines have been distributed in the U.S. It will likely be the first test of whether the vaccines and treatments would remain accessible if shifted to a commercial…

The federal government’s stores of a key Covid-19 antibody drug, a crucial weapon for keeping the infected out of the hospital, are expected to be used up in late August because pandemic funding is running out.Biden administration officials have told Congress that the government’s supply of the Eli Lilly & Co.therapy, the only antibody drug for treating nonhospitalized patients that was found to work against Omicron, could run out if pandemic funding isn’t renewed. The supply could be depleted before fall if the pace…

Photo: Shutterstock (Shutterstock)People with a severe form of baldness will now have a significant treatment option available. On Monday, the Food and Drug Administration approved baricitinib for treating alopecia areata. The drug, taken as a pill, is the first of its kind intended to treat the autoimmune disorder, though it’s already commonly used for other conditions like rheumatoid arthritis.Alopecia areata is caused by an overactive immune system that attacks hair follicle cells. Hair loss typically occurs before age…

Image: Shutterstock (Shutterstock)New preliminary research this week points to long term benefits from bariatric, or weight loss, surgery. The study found that people who underwent surgery were noticeably less likely to develop certain cancers over a ten-year period compared to similarly matched people with obesity who did not receive surgery. Those who did develop cancer were also less likely to die from it.The study was led by researchers at the Gundersen Lutheran Health System in Wisconsin. They examined the medical…

The gold rush for drugmakers making Covid-19 vaccines and treatments might be over, as demand plateaus, supplies turn ample and the pandemic evolves. Merck & Co. and Johnson & Johnson are among the companies cutting sales expectations for pandemic products this year as they assess the outlook. Analysts, meantime, are lowering sales estimates for Covid-19 drugs such as Pfizer Inc.’s antiviral Paxlovid, citing softening demand…